Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Amgen dismisses bone density concerns related to its weight-loss drug
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off more than $12 billion from the company's market value.
What are your questions about weight loss drugs?
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.
‘This Weight Loss Drug Helped My Mental Health Way More Than Any Other Medication’
The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental health challenges. Her story, here.
Amgen Says No Link Between MariTide And Changes In Bone Mineral Density
Wednesday said there is no association between administration of experimental weight loss drug MariTide and changes
Amgen sees no bone safety concerns around experimental obesity drug
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a day after data from an early-stage study dragged its stock 7% lower.
Amgen stock falls as analysts mull over weight loss drug's bone density data
Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.
Amgen MariTide bone mineral density loss data ‘leaked,’ says Cantor Fitzgerald
Cantor Fitzgerald tells investors that MariTide’s Phase 1 data includes “a big surprise” as the supplemental appendix file
Amgen rebounds after denying bone safety concerns linked to obesity drug
Amgen (NASDAQ:AMGN) shares spiked in the premarket on Wednesday after the company ruled out concerns over loss of bone mineral density linked to its obesity candidate MariTide, which led to a ~7% decline in its share price in the previous session.
Medical Xpress
18h
New weight loss drug target burns energy and lowers appetite—without the nausea and vomiting
Scientists at the University of Copenhagen have discovered a new
weight
loss
drug target that reduces appetite, increases ...
2h
on MSN
New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
Men's Journal on MSN
2h
Jim Gaffigan Reflects on Weight Loss Journey, How He Finally Slimmed Down
and is now opening up about his
weight
loss
journey. Speaking with Us Weekly this week ahead of his new Hulu special The ...
6h
9 Exercises Men Should Avoid for Weight Loss
Fitness experts reveal productive weight-loss tips for men, including the exercises they should avoid for weight loss.
New York Post on MSN
6h
NASA monitoring second stranded astronaut’s possible weight loss after raising alarm about colleague Sunita Williams’ health
And his mass seems to have gone down.” NASA is working to help astronaut Sunita Williams put on pounds after she had ...
5h
on MSN
Weight loss plans are less effective for many Black women − because existing ones often don’t meet their unique needs
Healthy diet and regular exercise are key to treating obesity. But the stress of everyday racism and sexism hinder Black ...
5h
America's Best Weight Loss Clinics & Centers 2025
Newsweek and Statista are partnering for the first time to name America's Best Weight Loss Clinics & Centers 2025, recognizing 200 facilities nationwide that help people make healthy lifestyle changes ...
2d
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
Hosted on MSN
7h
Amgen dismisses bone density concerns related to its new weight-loss drug
(Reuters) -Amgen said on Wednesday there was no link between its experimental
weight
-
loss
drug and changes in bone ...
BBC
37m
Call for more weight loss support to deter foreign treatment
More
weight
loss
surgery should be offered on the NHS to deter people from travelling abroad for treatment, campaigners ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Turkey
Ozempic
Novo Nordisk
CagriSema
Polly Sellman
Feedback